aTENSION.life raises USD 3M in seed funding led by Wlanholding to develop precision diagnostics for hypertension.
aTENSION.life raises USD 3M in seed funding led by Wlanholding to develop precision diagnostics for hypertension.
05/08/25, 8:11 AM
Location
Money raised
$3 million
Industry
health diagnostics
biotechnology
health care
Round Type
seed
Investors
Vp Venture Partners, E Qventure, Wlanholding
aTENSION.life, a Vienna-based startup, raised USD 3M in seed financing for its advanced mass spectrometry-based diagnostics. The funding round was led by Wlanholding, with participation from eQventure and VP Venture Partners. Dr. Werner Lanthaler has been appointed Chairman of the Supervisory Board
Company Info
Location
vienna, vienna, austria
Additional Info
At aTENSION, we are redefining the future of hypertension care. It is our mission to make advanced mass spectrometry diagnostics accessible to everyone.
Our ALDO+ testing platform sets new standards in precision diagnosis and personalized treatments enhancing the well-being and life quality of hypertensive patients. With just one blood sample it identifies underlying causes of uncontrolled hypertension and personalizes treatment therapies. ALDO+ is transforming hypertension diagnostics with unparalleled benefits for clinicians, labs and patients, delivering high diagnostic value, operational simplicity and cost efficacy.